New diabetes clinical trial: Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

Published on: July 14, 2024 at 11:00PM
Conditions: Essential Hypertension; Type 2 Diabetes; Nephropathy
Interventions: Drug: Sacubitril/Valsartan; Drug: Valsartan
Sponsors: Sichuan Academy of Medical Sciences; The Second Affiliated Hospital of Chongqing Medical University; Nanchong Central Hospital; The People's Hospital of Leshan; The Affiliated Traditional Chinese Medicine Hospital Of Southwest Medical University; Chengdu First people's hospital; Mianyang People's Hospital; Guan'an People's Hospital; Meishan Traditional Chinese Medicine Hospital; Qijiang District People's Hospital; Meishan People's Hospital; The First People's Hospital of Guangyuan; Dazhou Central Hospital
Not yet recruiting
https://ift.tt/015ETKY